EPCAM and hepatocellular carcinoma: In addition, pharmacologic treatment of HCC cells and CSCs using jasplakinolide and narciclasine significantly increased F-actin and cell stiffness (Figs. S2I and S9G) and suppressed the colony formation and growth, EpCAM+ fraction, and the expressions of self-renewal genes (Fig. S9H to L).